0001104659-24-062663.txt : 20240516
0001104659-24-062663.hdr.sgml : 20240516
20240516193124
ACCESSION NUMBER: 0001104659-24-062663
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240514
FILED AS OF DATE: 20240516
DATE AS OF CHANGE: 20240516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Herskowitz Neil
CENTRAL INDEX KEY: 0001298246
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38128
FILM NUMBER: 24957357
MAIL ADDRESS:
STREET 1: 2109 BROADWAY, SUITE 206
CITY: NEW YORK
STATE: NY
ZIP: 10023
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc.
CENTRAL INDEX KEY: 0001651407
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472568632
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 95 SAWYER ROAD
STREET 2: SUITE 110
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 95 SAWYER ROAD
STREET 2: SUITE 110
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
tm2414703-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-05-14
0
0001651407
Checkpoint Therapeutics, Inc.
CKPT
0001298246
Herskowitz Neil
95 SAWYER ROAD, SUITE 110
WALTHAM
MA
02453
1
0
0
0
0
COMMON STOCK
2024-05-14
4
A
0
32051
0.00
A
67174
D
COMMON STOCK
2024-05-14
4
A
0
50000
0.00
A
117174
D
The 32,051 shares of restricted Common Stock will vest on May 14, 2027, subject to Mr. Herskowitz's continued service on the board on such date.
Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Herskowitz's continued service on the board.
The 50,000 shares of restricted Common Stock will vest according to the following schedule, subject to Mr. Herskowitz's continued service on the board on each date: one third on May 14, 2027, one third on May 14, 2028, and one third on May 14, 2029.
/s/ James F. Oliviero, Attorney-in-Fact
2024-05-16